UHT UNIVERSAL HEALTH REALTY INCOME TRUST
Real Estate Investment Trusts · NYSE · SEC CIK 798783 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY-0.0%
TTM net income YoY12.4%
TTM EPS YoY11.5%
Revenue 3-yr CAGR1.4%
Net income 3-yr CAGR5.0%
Margins
Gross margin—
Operating margin35.9%
Net margin20.3%
FCF margin—
EBITDA margin64.2%
Returns
ROE13.5%
ROA3.5%
ROIC (approx.)19.8%
Asset turnover0.17x
Leverage & solvency
Liabilities / assets75.7%
Debt / equity0.00x
Current ratio—
Interest coverage—
Cash quality & payout
Operating cash flow / net income2.33x
Accruals ratio-4.7%
Payout ratio205.7%
Capex / revenue—
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 | FY20232023-12-31 | FY20222022-12-31 | FY20212021-12-31 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | $99.19M | $99.01M | $95.58M | $90.62M | $84.19M |
| Operating income | $34.76M | $36.80M | $31.35M | $30.67M | $28.86M |
| Net income | $17.61M | $19.23M | $15.40M | $21.10M | $109.17M |
| EBITDA | $63.62M | $64.22M | $59.08M | $57.22M | $56.34M |
| EPS (basic) | 1.27 | 1.39 | 1.12 | 1.53 | 7.94 |
| EPS (diluted) | 1.27 | 1.39 | 1.11 | 1.53 | 7.92 |
| Dividends declared per share | 2.96 | 2.92 | 2.88 | 2.84 | 2.80 |
| Weighted avg. shares (diluted) | 13.86M | 13.84M | 13.81M | 13.79M | 13.78M |
| Banking | |||||
| Net interest income | -$18.85M | -$18.84M | -$16.92M | -$10.76M | -$8.81M |
| Balance sheet | |||||
| Cash & equivalents | $6.69M | $7.10M | $8.21M | $7.61M | $22.50M |
| Intangibles | $5.64M | $7.33M | $9.11M | $9.45M | $9.97M |
| Total assets | $564.91M | $580.86M | $596.37M | $607.54M | $598.42M |
| Long-term debt | $374.77M | $368.41M | $359.66M | $343.05M | $329.05M |
| Total debt | $374.77M | $368.41M | $359.66M | $343.05M | $329.05M |
| Total liabilities | $412.52M | $401.32M | $395.44M | $378.44M | $363.09M |
| Shareholders' equity | $152.38M | $179.54M | $200.93M | $229.10M | $235.33M |
| Net debt | $368.09M | $361.31M | $351.45M | $335.44M | $306.55M |
| Shares outstanding | 13.87M | 13.85M | 13.82M | 13.80M | 13.79M |
| Cash flow statement | |||||
| Operating cash flow | $49.09M | $46.91M | $42.94M | $46.80M | $47.73M |
| Capital expenditure | — | — | $7.62M | $13.62M | $12.99M |
| Free cash flow | — | — | $35.32M | $33.19M | $34.74M |
| Investing cash flow | -$14.96M | -$13.88M | -$19.11M | -$36.67M | -$24.43M |
| Financing cash flow | -$34.55M | -$34.15M | -$23.23M | -$25.02M | -$6.54M |
| Depreciation & amortization | $28.86M | $27.42M | $27.73M | $26.56M | $27.48M |
| Stock-based compensation | $936,000 | $853,000 | $780,000 | $780,000 | $947,000 |
| Dividends paid | $41.03M | $40.39M | $39.77M | $39.18M | $38.53M |
Free plan shows the latest 5 periods; Pro shows all 17 🔒
· Financial companies (banks, insurers, …) usually do not report gross profit or operating income; bank revenue is net revenue (net interest income + noninterest income), smaller than "gross interest income + noninterest income".
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.